Comprised of some of the nation's most accomplished business leaders and distinguished academic medical researchers, the MMRC Board of Directors provides strategic and fiscal oversight to guide the Consortium's research efforts.

		W. Dana LaForge – Chairman Partner Brera Capital Partners, LLC W. Dana LaForge is a Partner at Brera Capital Partners with overall responsibility for all aspects of this $680 million private equity fund. Prior to joining Brera in 2006, Mr. LaForge ran Colonnade Financial Group, Inc., a private equity services firm he founded in June 1992 with the support of Deutsche Bank. At Colonnade he managed a portfolio of private equity investments owned by Deutsche Bank. Earlier in his career, Mr. LaForge was a Managing Director at Deutsche Bank Alex Brown where he headed the Financial Institutions Group in Investment Banking. While there, he primarily advised clients on merger and acquisition transactions after several years of trading mortgage backed securities. In addition to serving on the Board of Directors of the MMRF, Mr. LaForge serves on the Board of Directors of GAB Robins, NA, Residential Loss Control Holdings, Inc. and Western Industries. Mr. LaForge earned a BS from Washington and Lee University and an MBA from Harvard Business School. He lives in New York City with his wife, Kathleen McCabe and their two young daughters.
		Kenneth C. Anderson, MD Chief, Division of Hematologic Neoplasia Director, Jerome Lipper Multiple Myeloma Center Dana-Farber Cancer Institute Dr. Anderson graduated from Johns Hopkins Medical School. He trained in internal medicine at Johns Hopkins Hospital and completed hematology, medical oncology, and tumor immunology training at the Dana-Farber Cancer Institute. Dr. Anderson is the Kraft Family Professor of Medicine at Harvard Medical School and serves as Chief of the Division of Hematologic Neoplasia, Director of the Jerome Lipper Multiple Myeloma Center, and Vice Chair of the Joint Program in Transfusion Medicine at the Dana-Farber Cancer Institute. He received the Waldenstrom's Award in 2003 for his translational research directed to the development of novel therapeutics targeting the myeloma cell in its microenvironment. He serves as Chair of the National Comprehensive Cancer Network's Multiple Myeloma Clinical Practice Guidelines Committee, on the Board of Directors and as Chairman of the Scientific Advisors of the Multiple Myeloma Research Foundation, and is a Doris Duke Distinguished Clinical Research Scientist.
		Karen E. Andrews SVP, Legal and Business Affairs Hachette Book Group USA Karen E. Andrews is currently SVP, Legal and Business Affairs of Hachette Book Group USA in New York. Previously Karen was the General Counsel and Corporate Secretary of BBDO Worldwide, Inc. where she was responsible for the management of the legal activities of over 150 individual operating units throughout the world. Prior to joining BBDO Worldwide, Ms. Andrews was Associate General Counsel and Director of Television Business Affairs at Time Inc. Ms. Andrews began her career in law as a Litigation Associate at the New York law firm of Weil, Gotshal & Manges where she specialized in Entertainment Litigation. Ms. Andrews graduated cum laude from the University of Vermont with a Bachelor of Science degree in biology and earned her law degree, cum laude, from Temple School of Law. Ms. Andrews is a member of the American Bar Association and the New York State Bar Association. In 1998, Ms. Andrews co-founded the Multiple Myeloma Research Foundation with Kathy Giusti.
		Frank Douglas, PhD, MD Senior Fellow, Kauffman Foundation Partner, Pure Tech Ventures Founder, MIT Center for Biomedical Innovation Dr. Douglas advises the Kauffman Foundation as a Senior Fellow. He is also Partner of Pure Tech Ventures and Founder and first Executive Director of the MIT Center for Biomedical Innovation. At MIT, he was a professor at the Sloan School of Management and also held appointments in the departments of biology, biological engineering, and the Harvard-MIT Division of Health Sciences and Technology. Formerly, Dr. Douglas was Executive Vice President, Chief Scientific Officer, and a Member of the Board of Management at Aventis. He serves on the board of directors of a number of pharmaceutical companies. Dr. Douglas is the recipient of the 2007 Black History Makers Award and has been honored twice as the Global Pharmaceutical R&D Director of the Year. He has also received the Medal of Honor and an Honorary Professorship from the Johann Wolfgang von Goethe University, Frankfurt, Germany. Frank received his PhD in physical chemistry and MD from Cornell University. He did his internship and residency in internal medicine at the Johns Hopkins Medical Institution and a fellowship in neuroendocrinology at the National Institutes of Health.
		Kathy Giusti Founder and Chief Executive Officer Multiple Myeloma Research Foundation (MMRF) Multiple Myeloma Research Consortium (MMRC) Kathy Giusti is the Founder and Chief Executive Officer of the Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC). Together, the two organizations have developed innovative models that serve to rapidly break down barriers slowing multiple myeloma research and accelerate the development of next-generation treatments. Chief among these are an integrated clinical network of academic centers that collaboratively conduct early-stage clinical trials, as well as a state-of-the-art tissue bank that has advanced the science of biobanking and genomic studies and provides a foundation for the organizations’ pursuit of personalized medicine. Prior to founding the MMRF, Giusti was a pharmaceutical executive at G.D. Searle & Co., and previously held positions at Merck & Co. and the Gillette Company. Giusti, a multiple myeloma patient, was most recently named to the 2011 TIME 100 List of the world’s most influential people—a recognition she received for the progress she has made in accelerating the way research and drug development are conducted and, ultimately, dramatically improving the outlook for patients with multiple myeloma and other cancers. Giusti has also received a number of other awards for her leadership, including the American Association for Cancer Research (AACR) Centennial Medal for Distinguished Public Service, the Harvard Business School Alumni Achievement Award, and the Healthcare Businesswomen's Association's Woman of the Year Award. Giusti’s efforts have been featured on the Today Show, CBS Evening News, CBS This Morning, CNN Money, Fox News, and NBC Nightly News. She has also been recognized by several notable media outlets, including The Wall Street Journal, The New Yorker, Harvard Business Review, and The Economist. Giusti currently serves on the Executive Management Committee to Stand Up to Cancer and the Harvard Business School Advisory Board. She has previously served on several other boards, including the President’s National Cancer Advisory Board, the Board of Directors for IMS Health, and the Institute of Medicine's National Cancer Policy Board. Giusti received her MBA in general management from Harvard Business School and graduated from the University of Vermont magna cum laude with a Bachelor of Science in Biological Sciences.
		Stephen Grand President and Partner Grand-Sakwa Properties Mr. Grand has been President and Partner of Grand-Sakwa Properties, one of southeastern Michigan's major developers of residential and retail properties, since 1990. From 1980 to 2000, he was President and Owner of Deco-Grand, Inc., a manufacturer of precision components and assemblies for diesel engines and automotive industries. Mr. Grand has served on the boards of the Karmanos Cancer Institute, Focus Hope, and the American Technion Society, as well as on the Endowment Committee of the Jewish Federation of San Francisco. He is a member of the DeTocqueville Society of the United Way of Michigan and a member of the Northern California Presidents Organization. Mr. Grand received his Bachelor of Science and Master of Science degrees from the University of Michigan School of Engineering.
		Eugene P. Grisanti Retired Chairman, President and CEO International Flavors & Fragrances, Inc. Eugene P. Grisanti is the former Chairman, President and CEO of International Flavors & Fragrances, the world's largest flavor and fragrance company, a position he held for fifteen years, after serving as Senior Vice-President, General Counsel and other executive positions. He was a corporate attorney with the firm Fulton, Walter and Halley in New York City prior to joining IFF. Mr. Grisanti was elected to The Rockefeller University Board of Trustees in 1991, served as Chairman of The Rockefeller University Hospital Committee, and was elected Trustee Emeritus in 2000. Mr. Grisanti is Managing Director of The Metropolitan Opera, Vice-Chairman of The New York Botanical Garden, Chairman Emeritus of The New York City Ballet, and Director Emeritus of Lincoln Center for the Performing Arts. He is also a member of the Boards of the Ambrose Monell Foundation and the G. Unger Vetlesen Foundation. Eugene Grisanti received an A.B. from Holy Cross College, an LL.B. cum laude from Boston University, and an LL.M. from Harvard Law School.
		Allan Heller Operating Partner Water Street Healthcare Partners Mr. Heller is an Operating Partner with Water Street Healthcare Partners. Prior to joining Water Street Healthcare Partners, Mr. Heller was CEO of American Pharmaceutical Partners, an Investment Advisor on life science transactions to One Equity Partners, a private equity arm of JP Morgan Chase, and served as Senior Vice President and President of Global Renal Operations at Baxter Healthcare Corporation. Prior to these positions, Mr. Heller had an illustrious 23-year career at G.D. Searle, most recently as Executive Vice President and President of Searle Operations, and as a member of the Pharmacia Management Committee. Mr. Heller holds a Bachelor of Science degree in accounting from the University of Chicago and earned an MBA in finance from DePaul University.
		Anthony K. (Tony) Kesman Senior Partner Linden LLC Anthony Kesman is an Operating partner at Linden with more than thirty years experience in healthcare distribution, medical device and provider operations. Mr. Kesman began his career with American Hospital Supply Corporation’s distribution division, holding positions of increasing responsibility at successor companies Baxter International, Allegiance Healthcare and Cardinal Health. Prior to joining Linden, he served as an independent consultant and advisor to both public and privately held medical device, healthcare service and private equity firms. Mr. Kesman currently serves on the boards of directors of BarrierSafe Solutions International, Drayer Physical Therapy Institute, Focused Health Solutions, and the Scrip Companies. Previously, he served as a founding director of Source Medical Corporation, Canada’s largest medical supply distributor, as well as two terms as a director of the Health Industry Distributors Association (HIDA) Educational Foundation. He is also a member of the board of Children’s Memorial Medical Center, Northwestern Lake Forest Hospital, Junior Achievement of Chicago, the Multiple Myeloma Research Foundation and a member of the Economic Club of Chicago. Mr. Kesman holds an MBA from the Kellogg Graduate School of Management, Northwestern University and a Bachelor of Business Administration from the University of Iowa.
		Lori Tauber Marcus VP, Marketplace Activation Pepsi-Cola North America Foodservice Division Lori Tauber Marcus is a 21-year PepsiCo employee who is currently serving in the role of Vice President, Marketplace Activation for PepsiCo North America Beverages. She leads a team which brings all the marketing ideas to life on packaging, in the retail environment, and in the field with Bottling partners. Her team manages the national beverage marketing calendar, the innovation process and is the key linkage between the brand groups and the sales organization/Pepsi Bottling system. Ms. Marcus began her career at Pepsi as a Marketing Associate and held various roles in brand management, field marketing, and retail customer marketing. Ms. Marcus went on to become Director of the Foodservice Division's Restaurant Customer Marketing and Vice President, Marketing, of Pepsi's Foodservice Division before being appointed to her current position. In 2004, Ms. Tauber Marcus was elected to the YWCA's Academy of Women Leaders for her contributions to the MMRF. Ms. Tauber Marcus earned her bachelor's degree from the Wharton School at the University of Pennsylvania.
		Gerald McDougall Partner PricewaterhouseCoopers Mr. McDougall is Partner at PricewaterhouseCoopers Health Sciences Practice, where he provides services to academic medical centers, bioscience companies, pharmaceutical companies, research universities, colleges, health systems, and other research organizations. His practice provides a broad range of research business and compliance services, including strategic and business planning, financial analysis, research compliance, clinical research operations improvement, and information systems implementation services. In addition, his practice provides support services to the entire research continuum, from grant-funded basic science research, to translational research and clinical trials, including a dedicated group focusing on Clinical Research Consulting services.
		William S. McKiernan Chair and CEO CyberSource Corporation William McKiernan is the Chairman and Chief Executive Officer of CyberSource Corporation. Prior to founding CyberSource, Mr. McKiernan was President and Chief Operating Officer of McAfee Associates, now Network Associates; Mr. McKiernan held this position during the company's initial public offering. Before joining McAfee, Mr. McKiernan was Vice President of Princeton Venture Research, Inc. and held management positions at ROLM/IBM. In addition to serving on the Board of Directors of the MMRF, Mr. McKiernan is the West Coast Chairman of the Boston College Technology Council. Mr. McKiernan holds a Bachelor of Science from Boston College and an MBA from Harvard Business School.
		Chris A. McWilton President, U.S. Markets MasterCard Worldwide Chris A. McWilton is president of U. S. Markets for MasterCard Worldwide. In this capacity, Mr. McWilton oversees all of the company's U. S. activities including sales, business development, business strategy, and relationship management for card issuers, merchants and merchant acquirers. Prior to being appointed president of U. S. Markets in 2009, he served as president of Global Accounts, where he managed relationships on a global basis for the company's largest customers. He is a member of the company's Executive Committee. Mr. McWilton joined MasterCard in 2003 as corporate controller and was appointed chief financial officer in October of the same year. As CFO, he was responsible for all financial functions, including financial reporting, investor relations, planning, treasury, tax, and new markets and investments. Mr. McWilton led the effort to make MasterCard SOX 404 compliant and helped complete the company’s successful initial public offering (IPO) in May 2006. MasterCard’s IPO was the largest domestic IPO of 2006 and the 12th largest domestic IPO in U.S. history at the time. Prior to joining MasterCard, Mr. McWilton had a 22-year career with KPMG, where he specialized in financial and SEC reporting and was an SEC Reviewing Partner. Mr. McWilton earned a bachelor's degree in business administration in accounting, summa cum laude, from St. Bonaventure University and is a certified public accountant.
		Mike Mortimer Executive Vice President and Chief Administrative Officer Quintiles Transnational Corp. Mike Mortimer is Executive Vice President and Chief Administrative Officer of Quintiles Transnational Corp., which provides innovative development and commercialization solutions to the pharmaceutical and biotechnology industries, helping to bring new medicines to market and increase sales faster. He oversees the company's Human Resources, Corporate Communication, Legal and Risk Management, Real Estate and Facilities, and Global Security. He is responsible for managing a worldwide staff of more than 400 and an annual budget of over $350 million. Prior to joining Quintiles, Mr. Mortimer spent 10 years at Charles Schwab Corp. in a variety of executive positions, most recently as Senior Vice President of Human Resources for the retail and international divisions. He began his career in human resources at Sprint Corporation in 1986 and holds a bachelor's degree in behavioral sciences from Ohio State University.
		Charles B. Ortner Senior Partner Proskauer Rose LLP Charles B. Ortner is a Partner at the New York-based Proskauer Rose LLP law firm, where he represents many of the world's leading recording artists, songwriters, record producers, music publishers and record companies in litigation, as well as a counselor and strategic advisor. Mr. Ortner also serves as National Legal Counsel to the National Academy of Recording Arts & Sciences, Inc. (the Grammy Award organization). Previously, Mr. Ortner served as an Aide to Mayor John V. Lindsay of New York City, and as an Assistant to United States Attorney Whitney North Seymour, Jr. in the Southern District of New York. In addition to serving on the Board of Directors of the MMRF, Mr. Ortner was a member of the Board of Trustees of the T.J. Martell Foundation for Leukemia, Cancer and AIDS Research, and currently serves as the President of the Kanye West Foundation, an organization dedicated to using music education to combat the drop out problem faced by inner city schools. Along with his two children, Mr. Ortner established the Jane Ortner Multiple Myeloma Research Fellowship at New York Weill Cornell Medical Center. Mr. Ortner received his bachelor's degree from Washington University in St. Louis and received his law degree from Brooklyn Law School.
		David R. Parkinson, MD President and Chief Executive Officer Nodality, Inc. David R. Parkinson, MD, is President and CEO of Nodality, Inc., a San Francisco-based biotechnology company developing next-generation diagnostics in oncology and auto-immune diseases to enable more personalized treatment approaches. Before leading Nodality, Dr. Parkinson was Senior Vice President, Oncology Research and Development at Biogen Idec. He previously served as Vice President, Oncology Development, at Amgen and Vice President, Global Clinical Oncology Development at Novartis, where he was instrumental in bringing Gleevec® to market, completely transforming the treatment of Chronic myelogenous leukemia (CML). Prior to this, he served as the National Cancer Institute’s Chief of the Investigational Drug Branch, then as Acting Associate Director of the Cancer Therapy Evaluation Program. Dr. Parkinson has also served as the Chairman of the U.S. Food and Drug Administration (FDA) Biologics Advisory Committee and was a recipient of the FDA's Cody Medal. Dr. Parkinson received his medical degree from the University of Toronto Faculty of Medicine and he received Internal Medicine and Hematology/Oncology training at McGill University and at New England Medical Center.
		Marie Pinizzotto President and CEO Carol A. Ammon Foundation President Drug Safety Solutions, L.L.C. Marie Pinizzotto, M.D.,MBA is currently the president and CEO of the Carol A. Ammon Foundation, a foundation focused on health care, education and children with disabilities. She was also the president of Drug Safety Solutions, L.L.C., a Pharmacovigilance and Risk Management consulting company whose main focus is pharmacovigilance and risk management for narcotics and other high risk drugs. Prior to starting her consulting firm she worked at Endo Pharmaceuticals Inc. where she was Senior Director of the Global Safety and Pharmacovigilance department. Before working at Endo, she was a Senior Director of Report Evaluation and Safety Surviellance for the Women’s Health Division and Consumer Products at Wyeth. Dr. Pinizzotto received her B.S in Chemistry, magna cum laude, from the University of Pittsburgh, Pittsburgh Pennsylvania and her medical degree from Jefferson Medical College in Philadelphia. She completed her residency at The Medical Center of Delaware, where she practiced obstetrics and gynecology for nine years. Most recently, Dr. Pinizzotto earned her MBA at the University of Delaware where she maintained a 4.0 GPA. Currently Dr. Pinizzotto is a trustee of Christiana Care Hospital and a member of the Quality and Safety Committee. She is the named Chair, The Marie E. Pinizzotto, MD Chair of Academic Affairs, at Eisenhower Medical Center, Rancho Mirage, California. Dr. Pinizzotto sits on the boards of the following non-profit organizations: The Pregnancy Foundation, The Carol A. Ammon Foundation, which she is President and CEO. In additions she participates on the following two advisory boards: Scientific steering committee on Personalized Medicine for the Multiple Myeloma Research Foundation and Pediatric Disease Research for The Mario Batali Foundation. In addition she has been on the board for SOAR and Synova Pharmaceutical. She is also currently volunteering her time with Eisenhower Medical in Rancho Mirage, California as they embark on the development of a medical residency program and being considered as a trustee for the institution.
		Michael Reinert In that position, he has had the pleasure of working with great talent such as Stevie Wonder, Elton John, Taylor Swift, Amy Winehouse, Lil Wayne, Nelly, Jack Johnson and many other platinum selling acts. Prior to joining Universal ten years ago, Michael was the Vice President of Business & Legal Affairs for PolyGram Records, handling those duties for the legendary Verve Records label and Mercury Nashville Records where he worked with the likes of Herbie Hancock and Shania Twain. Michael started his career in private practice representing many artists, producers and writers before joining the corporate ranks. Michael was an Adjunct Professor of Law at his alma mater, The Benjamin Cardozo School of Law of Yeshiva University, for ten years teaching Contract Drafting and Negotiation in the Music Industry. He has been a contributing editor to the Practicing Law Institute volumes on the same subject and continues to lecture at various schools and seminars around the country. He currently serves as the Chairman of the Entertainment Law Initiative of the Grammy Foundation, a division of the National Academy of Recording Arts and Sciences, which focuses on legal education programs for aspiring entertainment attorneys. Michael attended the Horace Mann School for Boys in Riverdale (back then it was just for boys!) and Tulane University in New Orleans, a place he considers his second home. He lives in Manhattan with his wife of 30 years, Karen. They have one beautiful daughter, a wonderful son-in-law and two even more beautiful grandchildren.
		Donna Zaccaro Ullman President Homestead Finance LLC Donna Zaccaro Ullman is a Principal of Homestead Finance, LLC, a real estate investment company. Previous to this, she served as President of WhatGoesAround.org (WGA) a nonprofit, on-line charitable giving site that was acquired by Network for Good. Prior to that, Ms. Zaccaro Ullman was a longtime producer for the Today Show at NBC News. Ms. Zaccaro Ullman has also had careers in politics on campaigns for her mother Geraldine Ferraro; in public affairs at the Bedford Kent Group, a marketing and communications firm she co-founded; and in investment banking at Salomon Brothers, Inc. In addition to serving on the Board of Directors of the MMRF, she serves on the Board of Trustees at Grace Church School, an independent school in New York City. Ms. Zaccaro Ullman holds a Bachelor of Arts degree in Comparative Literature from Brown University and an MBA in General Business Administration from Harvard Business School.
		Meryl Zausner Chief Financial Officer Novartis Corporation Meryl Zausner is the Chief Financial Officer of Novartis Corporation and a member of the company's Executive Committee. Ms. Zausner has worked in the Consumer Products and Pharmaceutical industries for 27 years. Previously, she was Vice President and CFO of Novartis Oncology. In addition to her responsibilities as CFO, Ms. Zausner chaired the Novartis Pharmaceuticals 2006 & 2007 Global Diversity Council, of which she was a founding member. She was also a founding member of the U.S. EWIN (Empowering Women to Impact Novartis) Initiative. In 2007, she was named Healthcare Businesswomen Association's Woman of the Year. Before joining Novartis, Ms. Zausner held a variety of positions with the Colgate Palmolive Company and spent three years working in Public Accounting. She has degrees in Economics and Accounting from the University at Albany as well as her CPA in New York.